Two Sigma Investments, LP Morphic Holding, Inc. Transaction History

Two Sigma Investments, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$26.12 - $34.07 $2.07 Million - $2.7 Million	-79,331 Reduced 30.9%	177,420 $6.04 Million
Q1 2024 May 15, 2024	SELL	$26.64 - $40.31 $5.86 Million - $8.87 Million	-220,116 Reduced 46.16%	256,751 $9.04 Million
Q4 2023 Feb 14, 2024	BUY	$19.95 - $31.0 $1.25 Million - $1.94 Million	62,625 Added 15.12%	476,867 $13.8 Million
Q3 2023 Nov 14, 2023	BUY	$21.33 - $59.42 $8.54 Million - $23.8 Million	400,142 Added 2837.89%	414,242 $9.49 Million
Q2 2023 Aug 14, 2023	BUY	$34.33 - $62.11 $85,825 - $155,275	2,500 Added 21.55%	14,100 $808,000
Q1 2023 May 15, 2023	SELL	$26.01 - $48.69 $54,621 - $102,249	-2,100 Reduced 15.33%	11,600 $436,000
Q4 2022 Feb 14, 2023	BUY	$24.14 - $30.37 $330,718 - $416,069	13,700 New	13,700 $366,000
Q2 2022 Aug 15, 2022	BUY	$19.74 - $43.01 $1.59 Million - $3.47 Million	80,754 New	80,754 $1.75 Million
Q1 2022 May 16, 2022	SELL	$36.25 - $52.02 $166,750 - $239,292	-4,600 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$43.27 - $65.72 $110,035 - $167,125	-2,543 Reduced 35.6%	4,600 $218,000
Q3 2021 Nov 15, 2021	SELL	$53.61 - $67.5 $505,113 - $635,985	-9,422 Reduced 56.88%	7,143 $405,000
Q2 2021 Aug 16, 2021	SELL	$45.13 - $64.99 $1.93 Million - $2.78 Million	-42,790 Reduced 72.09%	16,565 $951,000
Q1 2021 May 17, 2021	BUY	$29.77 - $84.85 $926,382 - $2.64 Million	31,118 Added 110.2%	59,355 $3.76 Million
Q4 2020 Feb 16, 2021	BUY	$25.66 - $34.55 $724,561 - $975,588	28,237 New	28,237 $947,000

4.71M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.